Dr. Patrik Frei was the keynote speaker at BIO IP & Diagnostics Symposium (IPDx) on 29th of September 2017. During the session, the Venture Valuation CEO discussed the valuation of biotechnology companies and products and its link to IP. He gave a short introduction to risk-adjusted net present value calculations, the main value drivers and a looked at how these can drive deal terms and negotiations.
Tag: IPDx keynote speech
Archive
Categories
- Let’s Interview Series (56)
- News (48)
- Other Documents (12)
- Presentations (100)
- Reports and analyses (56)
- Whitepapers (4)
- Venture Valuation and Biotechgate to Participate in the 2024 BIO International Convention in San Diego
- Interviews with leading Life Sciences companies: Sound Wave Innovation
- Interviews with leading Life Sciences companies: Pixie Dust Technologies
- Venture Valuation/Biotechgate Announces Participation in Biotech Showcase, the J.P. Morgan 41st Annual Healthcare Conference 2024 and RESI
- Venture Valuation Strengthens its Presence in North America With Sales Team Expansion
Category Tags
409A valuation AI Medical Service AOT asset valuation Biotech firms Biotechgate Biotechgate Digital Partnering brain activity measuring breast cancer Cells clinical trial database Cold Ablation Robotguided Laser Osteotome cranio-maxillofacial surgery Cyrill Bätscher early digestive track cancer detection Ferring Pharmaceutical filming Fujieda Ayumi Funding future of life sciences Gergely Ivanyi German Biotech German Life Sciences GTAI Health Made in Germany Heartseed Inc. HelloPartnering in-licensing opportunities JPM San Francisco Kiyoshi Hasegawa life science database Lily MedTech Inc. medical image analysis NeU Corporation patrik frei product valuation RESI Rhine-Main-Neckar biotech SARS CoV 2 Shiho Azuma Tomohiro Tada valuation Valuation Experts XB-01 Yone Production Co Ltd